BioTaiwan 2017 – One Of the Largest Biotech Events In Asia

  • Research Stash
  • Events
  • 2K

The tentative agenda for BioTaiwan 2017 was recently announced, Now is its 16th year, BioTaiwan 2017 is 5 events in 1, including the BioBusiness Asia Conference, Greater China & Asia-Pacific Opportunities Conference, BioTaiwan Exhibition, Company Presentations, One-on-one Partnering and a full Seminar and Workshop program. It’s only a click away to discover the opportunities that await in biotech investment, collaboration, innovation, and services.

Bio-Taiwan-2017-Registration

Taiwan is undergoing a boom in biotechnology, rewarding years of dedicated effort from its stakeholders. More and more locally-developed drugs are entering late-stage clinical trials, and new companies, service providers, and manufacturing facilities are emerging to fill rapidly growing industry needs. Overseas interest is picking up as well, with licensing, partnering and investment agreements at an all-time high. The total market capitalization of local publicly-listed biotech companies has soared, increasing 700 percent since 2008’s capital market crash, rewarding stakeholders for their patience and support.

Bio-Taiwan-2017-Speakers.jpeg

The biotech industry in Taiwan has a set of unique characteristics and strengths that make it an appealing prospect to the global life science community looking for a partnership, investment or licensing opportunities. These include:

  1. Vibrant VC industry and capital markets
  2. Strong business and cultural ties to the Greater China market
  3. World-class clinical trial capability
  4. Transparent legal and business environment, with strong IP protection
  5. Well established private-public partnerships with deep innovation pipelines
  6. Highly-educated, motivated and cost-effective workforce
  7. Executives with overseas training, global view, and Big Pharma experience
  8. Strong government support, subsidies, and tax breaks

As healthcare is moving from a “one size fits all” model towards a more personalized approach, bringing together Taiwan’s newest diagnostic tools with precision therapeutics, existing strengths in ICT and device industries means that Taiwan is well placed to excel in this evolving healthcare ecosystem.

Subscribe to our YouTube Channel

Save the dates and join to experience the vibrancy, innovation, and inspiration of Taiwan’s biotech industry and explore the tremendous opportunities on offer at BioTaiwan 2017!

Why Attend BioTaiwan 2017?

Network with top executives, investors, experts and renown leaders from Taiwan, China, and beyond
Exhibit bio-clusters, technologies, unique products, and services
Discover biopharma innovations in Taiwan and Asia
Capture Greater China and Asia’s biotech market opportunities through Taiwan
Explore R&D, products, services and new partnerships

Taiwan’s biotech industry market value has reached 900bil TWD (30bil USD) and will soon approach its first trillion TWD as Taiwan becomes an integral part of the global biopharma industry chain. The government’s initiatives to support Taiwan’s biotech development and innovation are critical for continued strong growth momentum.

BioBuisness Asia explores such investment opportunities in Taiwan. The event takes an in-depth look at issues regarding bio-investing and future trends in biomedical and life sciences within the Asia region. In 2016, the BioTaiwan exhibition had a record number of participants, reaching a total of 605 exhibitors, 1,305 booths, and 100,786 plus visitors representing Taiwan, Japan, Korea, China, India, North America and countries from the European Union.

Taiwan Economy and Biotech Industry Ranked High Globally

  1. Investment Risk #3 (BERI)
  2. Entrepreneurship #7, #1 Asia (GEDI)
  3. Global Competitiveness #13 (IMD)
  4. Higher Education #12 (WEF)
  5. Innovation Capability #10 (WEF)
  6. Knowledge-Based Economy #13, #1 Asia (World Bank)
  7. Scientific American Biotech Global Ratings
    • – Overall Competitiveness #17
    • – Enterprise Support #6
    • – Intensity #9
    • – Foundation #1
    • – Market Cap #3 (after US, Australia)

Click here to register for BioTaiwan 2017 https://bio-taiwan.com/en/registration/plan

More Details:

BioTaiwan 2017

Date: June 28 (Wed.) – July 2 (Sun.)
Venue: TWTC Nangang Exhibition Hall (No. 1, Jingmao 2nd. Rd., Nangang Dist., Taipei City)

Contact:

For BioTaiwan 2017 Conferences

Wendy Hung wendy@taiwanbio.org.tw +886-2-2655-8692 ext. 13

For BioTaiwan 2017 Exhibition 

Heidi Weng heidi@chanchao.com.tw +886-2-2659-6000 ext. 263
Rich Lee rich@chanchao.com.tw +886-2-2659-6000 ext. 161

Source: BioTaiwan

 

Rate

Bio-Taiwan-2017-Speakers.jpeg

The biotech industry in Taiwan has a set of unique characteristics and strengths that make it an appealing prospect to the global life science community looking for a partnership, investment or licensing opportunities. These include:

  1. Vibrant VC industry and capital markets
  2. Strong business and cultural ties to the Greater China market
  3. World-class clinical trial capability
  4. Transparent legal and business environment, with strong IP protection
  5. Well established private-public partnerships with deep innovation pipelines
  6. Highly-educated, motivated and cost-effective workforce
  7. Executives with overseas training, global view, and Big Pharma experience
  8. Strong government support, subsidies, and tax breaks

As healthcare is moving from a “one size fits all” model towards a more personalized approach, bringing together Taiwan’s newest diagnostic tools with precision therapeutics, existing strengths in ICT and device industries means that Taiwan is well placed to excel in this evolving healthcare ecosystem.

Subscribe to our YouTube Channel

Save the dates and join to experience the vibrancy, innovation, and inspiration of Taiwan’s biotech industry and explore the tremendous opportunities on offer at BioTaiwan 2017!

Why Attend BioTaiwan 2017?

Network with top executives, investors, experts and renown leaders from Taiwan, China, and beyond
Exhibit bio-clusters, technologies, unique products, and services
Discover biopharma innovations in Taiwan and Asia
Capture Greater China and Asia’s biotech market opportunities through Taiwan
Explore R&D, products, services and new partnerships

Taiwan’s biotech industry market value has reached 900bil TWD (30bil USD) and will soon approach its first trillion TWD as Taiwan becomes an integral part of the global biopharma industry chain. The government’s initiatives to support Taiwan’s biotech development and innovation are critical for continued strong growth momentum.

BioBuisness Asia explores such investment opportunities in Taiwan. The event takes an in-depth look at issues regarding bio-investing and future trends in biomedical and life sciences within the Asia region. In 2016, the BioTaiwan exhibition had a record number of participants, reaching a total of 605 exhibitors, 1,305 booths, and 100,786 plus visitors representing Taiwan, Japan, Korea, China, India, North America and countries from the European Union.

Taiwan Economy and Biotech Industry Ranked High Globally

  1. Investment Risk #3 (BERI)
  2. Entrepreneurship #7, #1 Asia (GEDI)
  3. Global Competitiveness #13 (IMD)
  4. Higher Education #12 (WEF)
  5. Innovation Capability #10 (WEF)
  6. Knowledge-Based Economy #13, #1 Asia (World Bank)
  7. Scientific American Biotech Global Ratings

Click here to register for BioTaiwan 2017 https://bio-taiwan.com/en/registration/plan

More Details:

BioTaiwan 2017

Date: June 28 (Wed.) – July 2 (Sun.)
Venue: TWTC Nangang Exhibition Hall (No. 1, Jingmao 2nd. Rd., Nangang Dist., Taipei City)

Contact:

For BioTaiwan 2017 Conferences

Wendy Hung wendy@taiwanbio.org.tw +886-2-2655-8692 ext. 13

For BioTaiwan 2017 Exhibition 

Heidi Weng heidi@chanchao.com.tw +886-2-2659-6000 ext. 263
Rich Lee rich@chanchao.com.tw +886-2-2659-6000 ext. 161

Source: BioTaiwan

 

" }
Research Stash Weekly Review #33

Research Stash Weekly Review #33

Weekly Review #33 – Summary of the latest news In science and technology research across the world, carefully handpicked by team Research Stash

Read more

Stanford Professor Creates An Artificial Eclipse To Image Extrasolar Planets

As anyone anticipating this month’s eclipse knows, one way to dim a star is to block it with something else – the moon, perhaps. Or in the case of distant stars whose light masks orbiting exoplanets, a shade-throwing satellite might do.

  • News
  • 1.9K
Read more
Novel susceptibility gene for non-familial hypokalemic periodic paralysis

Novel Susceptibility Gene for Non-Familial Hypokalemic Periodic Paralysis

Researchers from Taiwan recently reported a novel susceptibility gene for non-familial hypokalemic periodic paralysis. This study was published in Neurology

  • News
  • 1.5K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit